Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites

ABSTRACT: The study designed is to evaluate the safety of Canady Helios Cold Plasma Scalpel (CHCPS) in patients with solid tumors with carcinomatosis scheduled to undergo surgical resection for cytoreduction. Patients with stage 4 resectable tumors as decided by a multidisciplinary disease management team may be included if the metastatic disease is non-synchronous (e.g. recurrent colorectal carcinoma with hepatic metastasis amenable for surgical resection).. Plasma is an ionized gas typically generated in high-temperature laboratory conditions. Plasma coagulators are currently used routinely as surgical tools with multiple applications that create temperatures between 37° C to 43°C and cause thermal injury. Earlier studies demonstrated the non-aggressive nature of cold plasma. As evidence accumulates, it is becoming clear that low-temperature cold plasma has an increasing role in biomedical applications.

DISEASE(S): Stage Iv Liver Cancer,Stage Iv Colon Cancer,Stage Iv Rectal Cancer,Stage Iv Small Intestinal Cancer,Stage Iv Breast Cancer,Stage Iv Gastric Cancer,Stage Iv Fallopian Tube Cancer,Stage Iv Bladder Cancer,Stage Iv Colorectal Cancer,Stage Iv Pancreatic Cancer,Lung Neoplasms,Stage Iv Non-small Cell Lung Cancer,Stage Iv Ovarian Cancer,Recurrent Malignant Solid Neoplasm,Stage Iv Prostate Cancer,Fallopian Tube Neoplasms,Stage Iv Lung Cancer,Carcinoma, Renal Cell,Intestinal Neoplasms,Stage Iv Renal Cell Cancer

PROVIDER: 2329956 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR